---
title: "Gout treatment: flare relief and longer-term control"
canonical_url: https://www.gout-life.com/treatments/
updated: 2026-10-29
medical_review: pending
---

# Gout treatment: flare relief and longer-term control

> General educational information, not medical advice, diagnosis, or treatment.

Gout treatment has different jobs. Flare medicines calm inflammation and pain. Urate-lowering medicines reduce the urate burden over time. Some people also receive an anti-inflammatory to help prevent attacks when long-term treatment is started or adjusted. Knowing which medicine does what makes the plan easier to follow. [S02] [S03]

## During a flare

Colchicine, NSAIDs, and corticosteroids are common first-line options. Suitability depends on kidney function, other conditions, other medicines, and your preferences. The right choice for someone else may be wrong for you. [S02] [S03]

## When to discuss long-term treatment

ACR strongly recommends urate-lowering therapy for tophi, gout-related damage on imaging, or at least two flares a year. Other situations receive conditional recommendations, including some first attacks with kidney disease, very high urate, or stones. NICE uses broader offer-and-discussion criteria. The decision should reflect your disease burden, risks, and priorities. [S02] [S03]

## Treatment needs a target and follow-up

Where recommended, clinicians start low and adjust the dose using blood urate and safety checks. A starting dose is not necessarily the dose that will reach target. Early flares can occur as urate changes, so preventive anti-inflammatory treatment is often part of the initial plan. [S02]

## Where the main medicines fit

- **Allopurinol:** ACR’s preferred initial urate-lowering option, including in chronic kidney disease.
- **Febuxostat:** another urate-lowering medicine, with a US cardiovascular death boxed warning and a restricted place after allopurinol is unsuitable or inadequate.
- **Probenecid:** increases urate removal through the kidneys; kidney function, stones, and interactions matter.
- **Specialist treatment:** options such as pegloticase or selected IL-1 treatment require specialist assessment and monitoring. [S02] [S11] [S12] [S13] [S14]

## Leave the appointment knowing the purpose

Ask what each medicine is for, how to take it, what target you are aiming for, what side effects need action, and when the next review is. Bring up costs and access too. A plan has to be workable as well as medically appropriate.

## Related pages

- [Urate-lowering therapy and prevention](https://www.gout-life.com/treatments/urate-lowering-therapy/)
- [Allopurinol](https://www.gout-life.com/treatments/allopurinol/)
- [Febuxostat](https://www.gout-life.com/treatments/febuxostat/)
- [Specialist and advanced gout treatment](https://www.gout-life.com/treatments/specialist-and-advanced-treatment/)
- [Targets, monitoring and follow-up](https://www.gout-life.com/treatments/targets-monitoring-and-follow-up/)

## Sources

- [S02: 2020 American College of Rheumatology Guideline for the Management of Gout](https://pmc.ncbi.nlm.nih.gov/articles/PMC10563586/)
- [S03: NICE NG219: Gout, diagnosis and management, recommendations](https://www.nice.org.uk/guidance/ng219/chapter/Recommendations)
- [S11: DailyMed: ULORIC febuxostat prescribing information](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54de10ef-fe5f-4930-b91d-6bbb04c664bd)
- [S12: DailyMed: Probenecid tablets prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2375d90-4132-4fb6-aee7-c4f9d11e98d5)
- [S13: DailyMed: KRYSTEXXA pegloticase prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e566303-d93a-4130-b764-25749829aa95)
- [S14: DailyMed: ILARIS canakinumab prescribing information](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e)

[S02]: https://pmc.ncbi.nlm.nih.gov/articles/PMC10563586/ "2020 American College of Rheumatology Guideline for the Management of Gout"
[S03]: https://www.nice.org.uk/guidance/ng219/chapter/Recommendations "NICE NG219: Gout, diagnosis and management, recommendations"
[S11]: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=54de10ef-fe5f-4930-b91d-6bbb04c664bd "DailyMed: ULORIC febuxostat prescribing information"
[S12]: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2375d90-4132-4fb6-aee7-c4f9d11e98d5 "DailyMed: Probenecid tablets prescribing information"
[S13]: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e566303-d93a-4130-b764-25749829aa95 "DailyMed: KRYSTEXXA pegloticase prescribing information"
[S14]: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e "DailyMed: ILARIS canakinumab prescribing information"

## Educational scope

Gout Life provides general educational information, not medical advice, diagnosis, or treatment. Talk with a qualified healthcare professional about symptoms, medicines, and treatment decisions. Do not delay medical care because of information on this site. If you think you may have a medical emergency, call your local emergency number.